Capabilities

Integrated across the product and the manufacturing network.

Drug Substance

Process development, scale-up, process characterization, technology transfer, control strategy, registration campaigns and commercial manufacturing.

Drug Product

Formulation, process development, scale-up, process optimization, registration manufacturing and lifecycle strategy.

Enabling technologies

Spray drying and technically complex intermediates for small-molecule products with formulation or bioavailability challenges.

Analytical and control strategy

Method lifecycle, qualification and validation strategy, specifications, impurities, stability and integrated product control.

CMC regulatory strategy

IND development, EOP2 preparation, pivotal-stage CMC strategy, NDA readiness, comparability and post-approval planning.

CDMO strategy and governance

Selection, due diligence, technology transfer, technical oversight, change control, issue escalation and executive governance.

Clinical supply

Demand planning, manufacturing, packaging and labeling strategy, IRT interfaces, distribution and supply-risk management.

Commercial readiness

Validation strategy, launch inventory, commercial manufacturing network, supply resilience and operating governance.

CMC organization leadership

Operating model, portfolio priorities, team build, external expert network, executive communication and decision governance.